Prevalence of metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran: A comparative analysis of six definitions

Endocrine Regulations

Volumn 47, Issue 3, 2013, Pages 111-120

  Esmailzadehha, N ^a   Ziaee, A ^a   Kazemifar, A M ^a   Ghorbani, A ^a   Oveisi, Sonia ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agreement; Definitions; Insulin resistance; Metabolic syndrome; Prevalence; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WORLD HEALTH ORGANIZATION;

AGREEMENT, INSULIN RESISTANCE, DEFINITIONS, PREVALENCE, METABOLIC SYNDROME, WAIST CIRCUMFERENCE.;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; IRAN; MALE; METABOLIC DISEASES; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; URBAN POPULATION; YOUNG ADULT;

EID: 84880986042     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2013_03_111     Document Type: Article

References (49)

1. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-53, 1998. http://dx.doi.org/10.1002/(SICI)1096-9136(199807)15:7539::AID-DIA6683.0. CO;2-S
2. Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group: The metabolic syndrome-a new worldwide definition. Lancet 366, 1059-1062, 2005. http://dx.doi.org/10.1016/S0140-6736(05)67402-8
3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645, 2009. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644
4. Alkerwi A, Donneau AF, Sauvageot N, Lair ML, Scheen A, Albert A, Guillaume M: Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study. BMC Public Health 11, 4, 2011. http://dx.doi.org/10.1186/1471-2458-11-4
5. Altman DG: Some practical statistics for medical research (1st ed.). Chapman and Hill, 1991.
6. Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP: Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 26, 713-719, 2010. http://dx.doi.org/10.1185/03007991003590597
7. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, Hajipour R: Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 12, 80-89, 2002.
8. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16, 442-443, 1999. http://dx.doi.org/10.1046/j.1464-5491.1999.00059.x
9. Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33, 351-75, 2004. http://dx.doi.org/10.1016/j.ecl.2004.03.005
10. Can AS, Bersot TP: Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health 7, 353, 2007. http://dx.doi.org/10.1186/1471-2458-7-353
11. Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J: International Diabetes Federation: Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 56, 552-558, 2007. http://dx.doi.org/10.1016/j.metabol.2006.12.003
12. DECODA Study Group: Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 76, 57-67, 2007. http://dx.doi.org/10.1016/j.diabres.2006.07.020
13. Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 23, 127-134, 2007. http://dx.doi.org/10.1002/dmrr.658
14. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32, 1092-1097, 2009. http://dx.doi.org/10.2337/dc08-1800
15. Desroches S, Lamarche B: The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab 32, 23-32, 2007. http://dx.doi.org/10.1139/h06-095
16. Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F: Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 7, 26, 2010a. http://dx.doi.org/10.1186/1743-7075-7-26
17. Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, Abbasi M, Asgari F, Haghazali M: Secular trends of obesity in Iran between 1999 and 2007: National surveys of risk factors of non-communicable diseases. Metab Syndr Relat Disord 8, 209-213, 2010b. http://dx.doi.org/10.1089/met.2009.0064
18. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28, 2745-2749, 2005.
19. Ford ES, Li C, Zhao G: Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2, 180-193, 2010. http://dx.doi.org/10.1111/j.1753-0407.2010.00078.x
20. Gavrila D, Salmeron D, Egea-Caparros JM, Huerta JM, Perez-Martinez A, Navarro C, Tormo MJ: Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity. BMC Public Health 11, 562, 2011. http://dx.doi.org/10.1186/1471-2458-11-562
21. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA: American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 24, e19-24, 2004. http://dx.doi.org/10.1161/01.ATV.0000112379.88385.67
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752, 2005. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404
23. Guerrero-Romero F, Rodriguez-Moran M: Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 28, 2588-2589, 2005. http://dx.doi.org/10.2337/diacare.28.10.2588a
24. Hanefeld M, Leonhardt W: Das metabolische syndrom. Dt Gesundh Wesen 36, 545-551, 1981.
25. Harzallah F, Alberti H, Ben Khalifa F: The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 23, 441-444, 2006. http://dx.doi.org/10.1111/j.1464-5491.2006.01866.x
26. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7, 220, 2007. http://dx.doi.org/10.1186/1471-2458-7-220
27. Kassi E, Pervanidou P, Kaltsas G, Chrousos G: Metabolic syndrome: definitions and controversies. BMC Med 9, 48, 2011. http://dx.doi.org/10.1186/1741-7015-9-48
28. Kelliny C, William J, Riesen W, Paccaud F, Bovet P: Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol 7, 27, 2008. http://dx.doi.org/10.1186/1475-2840-7-27
29. Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, Kim HR, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S: Detect-2 Collaboration: Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 6, 37-46, 2008. http://dx.doi.org/10.1089/met.2007.0024
30. Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D: Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care 29, 1414-1416, 2006. http://dx.doi.org/10.2337/dc06-0481
31. Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R: Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int J Public Health 57, 543-550, 2012. http://dx.doi.org/10.1007/s00038-011-0244-x
32. Ma WY, Li HY, Hung CS, Lin MS, Chiu FC, Lin CH, Shih SR, Chuang LM, Wei JN: Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. Diabetes Res Clin Pract 85, 335-341, 2009. http://dx.doi.org/10.1016/j.diabres.2009.06.020
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419, 1985. http://dx.doi.org/10.1007/BF00280883
34. Misra A, Wasir JS, Vikram NK: Action and research are needed for evaluation of optimal definitions of anthropometric parameters and metabolic syndrome for Asians. Diabetes Res Clin Pract 68, 178-179, 2005a. http://dx.doi.org/10.1016/j.diabres.2005.01.009
35. Misra A, Wasir JS, Vikram NK: Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition 21, 969-976, 2005b. http://dx.doi.org/10.1016/j.nut.2005.01.007
36. Moayeri H, Rabbani A, Keihanidoust ZT, Bidad K, Anari S: Overweight adolescents: A group at risk for metabolic syndrome (Tehran adolescent obesity study). Arch Iran Med 11, 10-15, 2008.
37. Motala AA, Esterhuizen T, Pirie FJ, Omar MA: The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care 34, 1032-1037, 2011. http://dx.doi.org/10.2337/dc10-1921
38. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421, 2002.
39. Qiao Q: DECODE Study Group: Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49, 2837-2846, 2006. http://dx.doi.org/10.1007/s00125-006-0438-6
40. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607, 1988. http://dx.doi.org/10.2337/diabetes.37.12.1595
41. Santos AC, Barros H: Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diab Vasc Dis Res 4, 320-327, 2007. http://dx.doi.org/10.3132/dvdr.2007.059
42. Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M: Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res 2009, 136501, 2009.
43. Skilton MR, Moulin P, Serusclat A, Nony P, Bonnet F: A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 190, 416-422, 2007. http://dx.doi.org/10.1016/j.atherosclerosis.2006.02.019
44. Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E: Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism 57, 355-361, 2008. http://dx.doi.org/10.1016/j.metabol.2007.10.010
45. Timoteo A, Santos R, Lima S, Mamede A, Fernandes R, Ferreira R: Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening? Rev Port Cardiol 28, 173-181, 2009.
46. Vikram NK, Pandey RM, Misra A, Sharma R, Devi JR, Khanna N: Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 19, 503-509, 2003. http://dx.doi.org/10.1016/S0899-9007(02)01083-3
47. Wasir JS, Misra A, Vikram NK, Pandey RM, Gupta R: Comparison of definitions of the metabolic syndrome in adult Asian Indians. J Assoc Physicians India 56, 158-64, 2008.
48. Zabetian A, Hadaegh F, Azizi F: Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 77, 251-257, 2007. http://dx.doi.org/10.1016/j.diabres.2006.12.001
49. Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S: Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Glob J Health Sci 5, 155-165, 2013.